blindness from glp 1 SURGE IN GLP-1 DRUGS LIKE OZEMPIC SPARKS THOUSANDS OF LAWSUITS OVER ALLEGED SIDE EFFECTS The medications, initially for type 2 diabetes, have driven widespread off-label weight-loss use amid reported gastrointestinal injuries and Possible Link Between GLP-1 RA
Description
Two practical implications follow
It is commonly prescribed for both type 2 diabetes and obesity
Treatment of primary neonatal mouse cardiomyocytes with liraglutide increases cAMP formation and reduces apoptosis, as indicated by inhibition of TNFa induction of caspase 3 activity [614]
Request academic re-use from www.copyright.com
With careful patient selection, thorough counseling, and consistent monitoring, microdosing could play a valuable role in optimizing therapy amid challenges in availability, affordability, and tolerability
Actions of glucagonlike peptide1 receptor ligands in the gut
